Xellia Enters 4 Year Collaboration to Develop New Antibiotics

News   Feb 27, 2013

 
Xellia Enters 4 Year Collaboration to Develop New Antibiotics
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

Molecular Atlas Maps Out the Blood Brain Barrier

News

The genes and structure of the diverse web of cells that supplies blood to the brain have been mapped in unprecedented detail.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE